MREO vs SCHD
Mereo BioPharma Group PLC ADR (MREO) versus SCHD (SCHD) — a side-by-side from cached financials, not a winner call.
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
SCHD (SCHD) common stock.
Latest reported MREO revenue for 2026-06-30 was $0. Net income was -$7.0M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. MREO currently screens at market cap $48.7M.
SCHD does not have a complete income-statement cache yet.
MREO currently screens at market cap $48.7M. SCHD currently screens at market cap $0.
Not investment advice. Open the MREO and SCHD stock pages for the full models.
Not investment advice.